PEPentwater Capital Management LP
Institutional investor · Portfolio as of Q2 2021
Top Holdings303 positions
MAXIM INTEGRATED PRODUCTS | 11.2M | $1.2B | 9.8% | — | — | 4 qtrssince 2020-Q3 | Increased 63 |
| 2.2M | $932.1M | 7.7% | — | — | — | Increased — | |
ALEXION PHARMACEUTICALS INC | 4.9M | $906.3M | 7.5% | — | — | 3 qtrssince 2020-Q4 | Increased 71 |
SLACK TECHNOLOGIES INC- CL A | 19.4M | $861.3M | 7.1% | — | — | 3 qtrssince 2020-Q4 | Increased 61 |
| 7.1M | $799.9M | 6.6% | — | — | 3 qtrssince 2020-Q4 | Increased 82 | |
NUANCE COMMUNICATIONS INC | 12.2M | $665.8M | 5.5% | — | — | 1 qtr | New 97 |
KANSAS CITY SOUTHERN | 2.1M | $585.2M | 4.8% | — | — | 2 qtrssince 2021-Q1 | Increased 93 |
PPD INC | 12.2M | $563.2M | 4.6% | — | — | 6 qtrssince 2020-Q1 | Increased 93 |
PROOFPOINT INC | 2.5M | $437.9M | 3.6% | — | — | 1 qtr | New 86 |
COHERENT INC | 1.4M | $381.4M | 3.1% | $67.70 | +8.14% | 2 qtrssince 2021-Q1 | Increased 68 |
| 1.2M | $328.6M | 2.7% | — | — | — | Increased — | |
TURQUOISE HILL RES LTD | 19.1M | $321.7M | 2.7% | — | — | 3 qtrssince 2020-Q4 | Increased 54 |
XILINX INC | 2.1M | $298M | 2.5% | — | — | 3 qtrssince 2020-Q4 | Decreased 0 |
CHANGE HEALTHCARE INC | 9M | $207.5M | 1.7% | — | — | 9 qtrssince 2019-Q2 | Decreased 0 |
PRA HEALTH SCIENCES INC | 1.2M | $204.9M | 1.7% | — | — | 2 qtrssince 2021-Q1 | Increased 62 |
GRACE W R & CO DEL NEW | 2.8M | $190.8M | 1.6% | — | — | 1 qtr | New 70 |
| 3.2M | $172M | 1.4% | — | — | — | New — | |
QTS REALTY TRUST INC-CL A | 2M | $154.6M | 1.3% | — | — | 1 qtr | New 69 |
P G & E CORP | 14M | $142M | 1.2% | $10.96 | -8.91% | 10 qtrssince 2019-Q1 | Decreased 0 |
| 1.4M | $133.9M | 1.1% | — | — | — | Increased — |
Pentwater Capital Management LP manages $12.1B across 303 positions as of Q2 2021. Top holdings: MXIM (9.8%), SPDR S&P 500 ETF TR puts (7.7%), ALXN (7.5%). Fund DNA: Momentum Trader. HoldingsIntel Score: 1.5/5.0.
Active quarter - 100 new positions, 117 exits, 52 increased. Top move: NUAN (NEW, conviction 97). Portfolio: $12.1B across 303 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR